Pulmonary Tuberculosis Clinical Trials
104 clinical trials for Pulmonary Tuberculosis across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis — RECRUITING · PHASE2
- Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial — RECRUITING · PHASE3
- A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis — RECRUITING · PHASE3
- ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD) — RECRUITING · PHASE2
- A PAN-USR TB Multi-Center Trial — RECRUITING · PHASE3
- PanACEA - STEP2C -01 — RECRUITING · PHASE2
- Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB — RECRUITING · PHASE2
- ATORvastatin in Pulmonary TUBerculosis — RECRUITING · PHASE2
- Novel Triple-dose Tuberculosis Retreatment Regimen — RECRUITING · PHASE3
- Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath — RECRUITING
- Rehabilitation of People With Post-tuberculosis Lung Disease — RECRUITING · NA
- A double-blind, multicentre, parallel group, randomised, controlled trial to evaluate the possible benefit of isoniazid dose adjustment according to the genotype for NAT2 (arylamine N-acetyltransferase type 2) in patients with pulmonary tuberculosis — TERMINATED · PHASE3
- TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment — COMPLETED · PHASE2
- Tuberculosis Cohort in the North of Paris — COMPLETED
- Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) — COMPLETED · PHASE2
- Effectiveness of Psychosocial Counseling in Patients With a New Tuberculosis Diagnosis — NOT_YET_RECRUITING · NA
- Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis — ACTIVE_NOT_RECRUITING · PHASE2
- Artificial Intelligence-driven Tuberculosis Landscape Analysis & Stratification Research — NOT_YET_RECRUITING
- Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis — TERMINATED · PHASE2
- Virtual Reality Cave vs. Simulated Home for Community Nursing Education: A Crossover Trial Comparing Student Competence, Confidence, and Satisfaction — COMPLETED · NA
- AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCT — NOT_YET_RECRUITING · PHASE2
- Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BLMZ Chinese Cohort — NOT_YET_RECRUITING · PHASE3
- I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis — ACTIVE_NOT_RECRUITING · NA
- Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis — COMPLETED
- PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE) — COMPLETED · PHASE2
- A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TB — COMPLETED · PHASE3
- Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BDLL Chinese Cohort — ACTIVE_NOT_RECRUITING · PHASE3
- Ultra-Short Regimen for Elderly DS-TB — NOT_YET_RECRUITING · PHASE3
- Phase II study on the safety and efficacy of cysteamine in association with standard tuberculosis therapy for the treatment of patients with pulmonary tuberculosis: a new therapy for tuberculosis directed at the host. — TERMINATED · PHASE2
- Breathing Exercise and Tele-Nursing Support for Patients With Tuberculosis: A Single-Group Experimental Study — COMPLETED · NA
- Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study — NOT_YET_RECRUITING
- Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis:Contezolid, Delamanid and Bedaquiline Cohort — ACTIVE_NOT_RECRUITING · PHASE3
- The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB) — OTHER · PHASE4
- Using Biomarkers to Predict TB Treatment Duration — COMPLETED · PHASE2
- Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis — COMPLETED · PHASE2
- Prokinetic Effect of Selected Nutraceuticals — COMPLETED · NA
- Epidemiological Study of Hospitalized Children for Pulmonary Tuberculosis at Strasbourg University Hospitals — OTHER
- StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis — COMPLETED · PHASE2
- Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081 — COMPLETED · PHASE2
- Assessing PA-824 for Tuberculosis (the APT Trial) — COMPLETED · PHASE2
- NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis — COMPLETED · PHASE2
- Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis — COMPLETED · PHASE2
- PanACEA Sutezolid Dose-finding and Combination Evaluation — COMPLETED · PHASE2
- A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis — COMPLETED · PHASE3
- Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases — COMPLETED · NA
- Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB — COMPLETED
- Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients — OTHER · PHASE4
- Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia — COMPLETED · NA
- Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis — COMPLETED · PHASE2
- Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis — OTHER
Refine this search